[1]
“Comparison of Efficacy of Intravenous Amikacin with Intravenous Cefoparazone/Sulbactum in Urinary Tract Infections Caused by Escherichia Coli Indiabetic Patients”, mfm, vol. 30, no. 8, May 2024, Accessed: Jun. 01, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3756